Physician profile
David Jinich
NPI 1861447500
$38,658.12
in general payments reported to CMS, 2019-2025
24 companies · $584 in 2025
The $584 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,996 · 2020: $13K · 2021: $15K · 2022: $4,390 · 2023: $1,739 · 2024: $107 · 2025: $584.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,634 · Travel and Lodging: $797.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,634.26 |
| Travel and Lodging | $796.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $30,307.89 | 2019-2022 | |
| Abbott Laboratories | $3,404.22 | 2019-2025 | Armada, Ensite, Jot Dx |
| Penumbra, INC. | $1,830.71 | 2019-2021 | |
| Medtronic, INC. | $1,324.84 | 2021-2023 | Micra |
| E.R. Squibb & Sons, L.L.C. | $467.52 | 2022-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $213.16 | 2019-2023 | Lux-Dx Insertable Cardiac Monitor |
| Medtronic Vascular, INC. | $188.47 | 2019-2020 | |
| Shockwave Medical, INC | $129.67 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Terumo Medical Corporation | $127.71 | 2020-2021 | |
| Cardiovascular Systems INC. | $109.94 | 2021 | |
| Novartis Pharmaceuticals Corporation | $92.69 | 2022-2025 | |
| Pfizer INC. | $88.74 | 2021-2025 | |
| Zoll Respicardia, INC. | $66.25 | 2023 | Remede System |
| Philips North America LLC | $60.84 | 2023 | |
| Janssen Pharmaceuticals, INC | $46.32 | 2020-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bridgebio Pharma, INC. | $41.19 | 2025 | Attruby |
| Merck Sharp & Dohme LLC | $33.27 | 2025 | Verquvo |
| Amgen INC. | $25.54 | 2022 | |
| Inari Medical, INC. | $19.76 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $19.16 | 2024 | Arcalyst |
| Astrazeneca Pharmaceuticals LP | $17.13 | 2023 | Brilinta |
| Anumana, INC. | $15.08 | 2025 | Ecg-Ai Lef |
| Baxter Healthcare | $14.14 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Astellas Pharma US INC | $13.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Jinich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.